News
Pep Talk March 2025
In our March newsletter we celebrate some exciting updates! Our first products in partnership with StemCultures, and more on the way as we collaborate with Tolemy Bio. We also introduce our new differentiation kits, which contain everything you need for iPSC culture and differentiation.
Unexpected consequences: growth factor cross-contamination in mammalian and E. coli expressed growth factors
At Qkine we have repeatedly highlighted the need for stricter process and quality control in the manufacture of high purity in recombinant growth factors to prevent cross contamination with related growth factors. Contamination with other bioactive proteins leads to lack of inter and intra-lab reproducibility, or perhaps most concerningly incorrect scientific conclusions.
Qkine and WildBio collaborate to progress cultivated meat from wild game species
For the cultivated meat industry, the goal is to produce a quality raw material quickly and at a reduced cost. At WildBio, with help from Qkine, we are harnessing the power of cells from wild game species in South Africa.
My first cell ag conference: Waking up to the issues of meat
After attending her first alternative protein and cellular agriculture conference, the Bezos Centre for Sustainable Protein scientific kick-off, Liz describes what she learned about the need for alternative proteins and securing a sustainable future food source.
Qkine and Tolemy Bio partner to advance media and protein optimization for cell therapy manufacturing
Qkine, a leading recombinant protein manufacturer, and Tolemy Bio, a pioneer in custom cell culture media design using AI, are excited to announce a collaborative partnership to drive innovation in cell and gene therapy (CGT) manufacturing.
Protein tags, why and why not?
Protein tags are useful tools for affinity purification and other biochemical applications, but unnecessary tagging of proteins can cause issues. Read our latest blog and discover - Protein tags, why and why not?
Pep Talk January 2025
We're looking forward to what 2025 will bring and would like to wish everyone a very happy and prosperous New Year with our first newsletter of 2025. Featuring new distributors, events and application notes.
Qkine announces partnership with REPROCELL
Qkine Ltd., a specialist bioactive protein manufacturer with its core technology developed at the University of Cambridge, and REPROCELL Inc., Japan’s first and leading induced pluripotent stem cell (iPSC) company, have partnered to globally distribute high-quality proteins such as growth factors and cytokines manufactured by Qkine.
Event – Advanced Therapies Week – BIA Pavilion
We’re excited to announce that we will be taking part in Advanced Therapies Week 2025, happening from January 20-23, 2025, in Dallas, Texas. This landmark event, which will be held in this vibrant city for one year only, promises to be a must-attend for anyone in the advanced therapies field.
#FridayRead 03 January 2025
To start off the New Year, this week's #FridayRead is from a lab close to our hearts. In collaboration with Qkine the team in Alessandro Bertero’s lab at the University of Turin have developed optimized media for the maintenance of human induced pluripotent stem cells (hiPSCs).
Qkine join forces with Culturon to deliver cutting-edge solutions for the stem cell and life science industries
We are delighted to share that Culturon and Qkine have joined forces to deliver cutting-edge solutions for the stem cell and life science industries.
Qkine Product Launch Class of 2024
Class of 2024: celebrating the products launched in 2024 including expanding our hematopoietic range and adding tuna, salmon and eel FGF-2!
Pep Talk December 2024
In our final newsletter of 2024, we highlight our collaboration with cutting-edge cell-line specialists inscreenex to define TGF beta family activity; celebrate efforts to unite the UK stem cell community and if you are quick, you can benefit from our end-of-year promotion and receive a third free growth factor when you buy two products, a great chance to stock up.
Leighton shares his journey at Qkine
In our latest career blog our Senior Cell Scientist Leighton shares his experience and journey at Qkine.
Qkine and inscreenex collaborate to test cell models for drug discovery, disease modeling, and personalized medicine
Through its pioneering cell-type-specific immortalization technology, inscreenex empowers scientists to overcome the limitations of primary cell cultures, offering long-lasting and functional cell lines that are ideal for applications in drug discovery, disease modeling, and personalized medicine. Collaboration with Qkine merges their expertise with that of Qkine in complex protein manufacturing and engineering to allow testing and validation of cell responses in disease modelling.